SIRNAOMICS-B 02257Hong Kong Stock Exchange

3.7951.07%( +0.040 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SIRNAOMICS-B (02257) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2021-12-30
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG2050P1028

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-794.46M114/125

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
圣诺医药 Executive Director
潘洪辉 Executive Director
殷惠军 Non-Executive Director
王宇山 Independent Non-Executive Director
张鹏 Independent Non-Executive Director
卢懿杏 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-05.

About this page

This page shows SIRNAOMICS-B (02257) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.